Cephalexin Concentrations in Sputum During Acute Respiratory Infections
- 1 June 1973
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 3 (6) , 703-707
- https://doi.org/10.1128/aac.3.6.703
Abstract
In 20 patients with acute pulmonary infections, sputum purulence, sputum volume, and concentration and excretion of cephalexin in the sputum significantly decreased concurrently during therapy. The concentration of cephalexin in the serum remained unchanged. Significant correlations were observed between drug concentrations in sputum and serum and between drug excretion in sputum and concentration in serum. These observations may be explained by decreased integrity of the “blood-bronchus barrier” during inflammation, with diffusion of serum into bronchial mucus, without the necessity of postulating active transport.Keywords
This publication has 11 references indexed in Scilit:
- Ampicillin levels in sputum, serum, and salivaThorax, 1970
- Some principles in the chemotherapy of bacterial infections. II.BMJ, 1969
- In vitro antimicrobial activity and human pharmacology of cephalexin, a new orally absorbed cephalosporin C antibiotic.1969
- Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine.1968
- In vivo penetration of antibiotics into sputum in cystic fibrosis.Archives of Disease in Childhood, 1968
- A Guide to Use of Antibiotics in Patients with Renal DiseaseAnnals of Internal Medicine, 1967
- Some observations on the penetration of antibiotics through mucus in vitroJournal of Clinical Pathology, 1966
- Penicillin Levels in SputumThorax, 1965
- TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN Some Pharmacological ObservationsThe Lancet, 1965
- Ampicillin in the Therapy of Chronic BronchitisPostgraduate Medical Journal, 1964